Singulex Inc., the privately held immunodiagnostics company based in Alameda, CA, is close to market launch of its Clarity in vitro diagnostic system. The fully automated platform is designed to bring the benefits of the company’s Single Molecule Counting (SMC) technology to hospital and reference laboratories.
Singulex bills its SMC technology as “the backbone of next generation immunodiagnostics, because it offers “unprecedented sensitivity and dynamic range...